Inconsistent selection and definition of local and regional endpoints in breast cancer research. Issue 13 (13th October 2014)

• Record Type: Journal Article
• Authors: Moossdorff, M.; van Roozendaal, L. M.; Schipper, R.‐J.; Strobbe, L. J. A.; Voogd, A. C.; Tjan‐Heijnen, V. C. G.; Smidt, M. L.
• Is Part Of: British journal of surgery. Volume 101:Issue 13(2014)
• Page Start: 1657
• Page End: 1665
• Publication Date: 2014-10-13
• Subjects: Surgery -- Periodicals; 617.005
• DOI: 10.1002/bjs.9644
• Languages: English
• ISSNs: 0007-1323

Abstract

<abstract abstract-type="main" id="bjs9644-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bjs9644-sec-0001" sec-type="section"> <title>Background</title> <p id="bjs9644-para-0001">Results in breast cancer research are reported using study endpoints. Most are composite endpoints (such as locoregional recurrence), consisting of several components (for example local recurrence) that are in turn composed of specific events (such as skin recurrence). Inconsistent endpoint selection and definition might lead to unjustified conclusions when comparing study outcomes. This study aimed to determine which locoregional endpoints are used in breast cancer studies, and how these endpoints and their components are defined.</p> </sec> <sec id="bjs9644-sec-0002" sec-type="section"> <title>Methods</title> <p id="bjs9644-para-0002">PubMed was searched for breast cancer studies published in nine leading journals in 2011. Articles using endpoints with a local or regional component were included and definitions were compared.</p> </sec> <sec id="bjs9644-sec-0003" sec-type="section"> <title>Results</title> <p id="bjs9644-para-0003">Twenty‐three different endpoints with a local or regional component were extracted from 44 articles. Most frequently used were disease‐free survival (25 articles), recurrence‐free survival (7), local control (4), locoregional recurrence‐free survival (3) and event‐free survival (3). Different endpoints were used for similar outcomes. Of 23 endpoints, five were not defined and 18 were defined only partially. Of these, 16 contained a local and 13 a regional component. Included events were not specified in 33 of 57 (local) and 27 of 50 (regional) cases. Definitions of local components inconsistently included carcinoma <italic>in situ</italic> and skin and chest wall recurrences. Regional components inconsistently included specific nodal sites and skin and chest wall recurrences.</p> </sec> <sec id="bjs9644-sec-0004" sec-type="section"> <title>Conclusion</title> <p id="bjs9644-para-0004">Breast cancer studies use many different endpoints with a locoregional component. Definitions of endpoints and events are either not provided or vary between trials. To improve transparency, facilitate trial comparison and avoid unjustified conclusions, authors should report detailed definitions of all endpoints.</p> </sec> </abstract>